Introduction
Polychlorinated biphenyls (PCBs) are widespread persistent organic pollutants linked to numerous human health problems, with the most serious effects seen in children of exposed mothers (Ross, 2004; Schantz et al., 2003; Jacobson and Jacobson, 2003) . They are number 5 on the U.S. government's list of priority pollutants (ATSDR, 2015) . Worldwide, an estimated 200 billion kg remain in the environment (WHO World Health Organization, 2003) . The primary route of exposure is contaminated food, especially fatty fish, meat and dairy products (Malisch and Kotz, the wide variation in CYP1A2, we used wild type Cyp1a2(+/+) mice and Cyp1a2(À/À) knockout mice (Denison and Faber 2017; Nebert, 2017; Nebert and Dalton, 2006) . We previously showed that both high-affinity Ahr b Cyp1a2(À/À) knockout mice and poor-affinity Ahr d Cyp1a2(À/À) mice were more susceptible to learning and memory deficits when exposed to an environmentally relevant mixture of PCBs during gestation and lactation compared with Ahr b Cyp1a2(+/+) wild type mice (Curran et al., 2011a (Curran et al., ,b, 2012 . The studies described here extend those findings by testing the hypothesis that there is similar genetic susceptibility to PCBinduced motor deficits. Our motor battery was also designed to help clarify if PCBs affect motor function by disruption of nigrostriatal pathways or primarily target the cerebellum.
Materials and methods

Animals
Three genotypes of mice were included. High-affinity Ahr bCyp1a2(+/+) wild type mice were purchased from The Jackson Laboratory (Bar Harbor, ME) as C57BL/6J mice, which was the background strain for the two knockout lines used: Ahr b Cyp1a2
(À/À) and poor-affinity Ahr d Cyp1a2(À/À). All animals were housed in standard shoebox polysulfone cages with corncob bedding and one 5.1 cm 2 nestlet per week as enrichment. Water and Lab Diet 5015 chow were provided ad libitum.
Animals were kept on a 12 h/12 h light-dark cycle with all experiments conducted during the light cycle. Genotype was confirmed at the end of the behavior experiments. All experiments were approved by the Northern Kentucky University Institutional Animal Care and Use Committee. All husbandry and handling was in accordance with the Eighth Guide for the Care and Use of Laboratory Animals and the ARRIVE guidelines.
Breeding
Nulliparous females between 2.5 and 4 months of age were mated on a four-day breeding cycle with males of the same genotype. Females were separated from males the morning when a vaginal plug was found. Litters were culled or cross-fostered to balance litter size at 6 pups per dam, matching pups with dams of the same genotype and treatment. Pups were weaned at postnatal day 25, group housed by genotype, sex and treatment, and behavioral testing began at P60.
Treatments
We used the same dosing regimen (Table 1) described in our prior studies (Curran et al., 2011a,b) , which was based on the toxic equivalency factors for coplanar PCBs 77, 126 and 169. Noncoplanar (PCB 105, 118, 138, 153, 180) congeners were selected based on reports of their high toxicity and prevalence in the human food supply (Van den berg et al., 2006; Costabeber et al., 2006; Langer et al., 2007) . Controls were treated with the corn oil vehicle (Kroger, unstripped). Dams were randomly assigned to treatment groups and treated by gavage at a volume of 10 ml/g body weight. at gestational day 10 (GD 10) and postnatal day 5 (PND 5). The PCB doses used in the current study were higher than typical human exposures, but consistent with risk assessment principles requiring higher doses of a toxicant to observe toxicity in the short timeframe of a typical animal study (Doull, 2003) and at the low end of cumulative exposures used in other rodent studies of PCB neurotoxicity (Lein et al., 2007; Lee et al., 2012) .
Chemicals
Polychlorinated biphenyl congeners were ordered from UltraScientific (N. Kingstown, RI). Unless otherwise noted, all other reagents were purchased from Sigma-Aldrich (St. Louis, MO).
Western blot
CYP1A1 induction was confirmed in high-affinity Ahr b mice using livers collected from P30 littermates of animals used in behavior. The liver was removed, rinsed in ice-cold phosphate buffered saline, blotted and stored at À80 C until processing. Approximately 500 mg of tissue per animal was homogenized using a polytron homogenizer and a buffer of 0.25 M sucrose, 10 mM HEPES, 1 mM Na2EDTA, and 1 mM EGTA with 0.1% bovine (Brown, 1988) . Separated proteins were transferred to PVDF membranes. Western blot analysis was performed using rabbit polyclonal anti-CYP1A1 antibody (Millipore AB1247) and a horseradish peroxidase-conjugated secondary antibody (Daiichi). The SuperSignal Pico enhanced chemiluminescence system (Pierce) was to detect primary antibody binding, with exposure times ranging from 10 to 60 s. N = 4-6 per group.
EROD assay
Microsomes from liver, cortex and cerebellum were prepared as described in the previous section to measure CYP1A1 enzymatic activity in PCB-exposed and control animals using the well-known ethoxyresorufin-O-deethylase (EROD) assay. Unknowns were quantified using a standard curve, and purified human CYP1A1 was used as a positive control following the methods of Thompson et al. (2010) . N = 5-9 per group.
Glutathione assay
Reduced glutathione (GSH) and oxidized GSSG were measured in liver, cortex and cerebellum using a standard kit (Cayman Chemicals, Ann Arbor MI) and following the manufacturer's protocols N = 3-5 per group.
Motor function tests
One male and one female from each litter were randomly assigned to behavioral testing. A comprehensive battery of tests was used to assess function in both the cerebellum and nigrostriatal pathways. Each animal went through the same experimental protocol, and each animal was limited to one test per day. Experiments were conducted within a 4 h time block to avoid confounding by circadian rhythms. Experiments are described in the order in which they were performed. Animal handlers and those analyzing the data were naïve to the genotype and treatment. N ! 16 litters per group (Table 2 ) Video demonstrating the techniques and equipment can be viewed at: https:// www.youtube.com/watch?v=TximAxZcomk.
Rotarod
Mice were acclimated to the rotarod apparatus for one day at 0 rpm and one day at a constant 2 rpm speed. Testing was conducted with the rotarod set to accelerate from 1 to 20 rpm over 180 s, for a maximum trial of 300 s. Latency to fall was recorded. Mice received 3 trials per day for 5 days with an inter-trial interval of 5 min. Rotarod is one of the most widely used tests of cerebellar function (Nadler et al., 2006) .
Gait analysis
The hind paws of mice were coated with nontoxic paint, then the mice walked down a 5 cm Â 28 cm alley into a black-lined escape cage. Two days were used for training followed by a test day with three trials per day. Trials where mice ran or stopped were not included in the analysis. Stride length and stride width were measured, and the differential between the longest and shortest strides was calculated during analysis. Deficits in hind limb control result in uneven gait patterns in rodents (Fleming et al., 2004) . Striatal lesions would result in more steps and shorter steps. Cerebellar lesions would result in unequal stride lengths. No mouse received more than 6 trials over 2 days before completing the task successfully.
Sticker removal
The sticker removal test was used to assess sensorimotor function (Schallert, 1988) . Mice must detect the presence of a round 6.35 mm sticker on their snout and use their front paws to remove it. The latency to remove the sticker was recorded. Each mouse received a single test unless the sticker fell off or was not correctly placed on the snout. Mice not removing the sticker after 60 s were assigned a time of 60 s. No mouse received more than 3 trials.
Pole test
The pole test measures gross motor coordination and can detect impairments in nigrostriatal pathways (Fernagut et al., 2003; Sedelis et al., 2001) , which can be reversed by treatment with L-DOPA (Matsuura et al., 1997; Ogawa et al., 1985 Ogawa et al., , 1987 . A 50 cm vertical pole of 8 mm diameter was placed inside the animal's home cage. Each mouse was placed at the top of the pole, with its head facing upward. Mice were trained to turn and climb down to the home cage for 2 days and tested on the Day 3. The time to turn and time to descend were recorded. Each mouse received 5 trials per day with a 60 s inter-trial interval.
Challenging balance beam
Mice were trained for two days (5 trials per day) on a smooth beam decreasing in width from 35 to 5 cm. Each beam segment was 25 cm in length for a total length of 1 m. Mice were tested on the third day with the beam covered by a wire mesh. Latency to cross, steps and slips were recorded, and the slip:step ratio was calculated during analysis. This protocol has been successfully used to assess nigrostriatal deficits in alpha-synuclein overexpressing mice and other PD mouse models (Schultheis et al., 2013; Fleming et al., 2004) .
Data analysis
Behavior and EROD data were analyzed using SAS Proc Mixed Models Analysis of Variance with litter as the unit of analysis. We examined the main effects of treatment, genotype, and sex and their interactions. For rotarod, day was included as a repeated measure. When differences were found, we examined simple effects using the SAS "Slice" command with a correction for multiple post-hoc analyses. Measurements of reduced glutathione and oxidized GSSG were compared against control mice using the Holm-Sidak method. Data are presented as least square means AE the standard error of the mean (SEM). Western blot data is simply reported as CYP1A1 present or not, indicating whether or not AHR activation occurred. (À/À) knockout mice, but CYP1A1 protein was also present in PCBtreated Ahr b Cyp1a2(+/+) wild type mice (Fig. 1) . The EROD assays showed significantly higher CYP1A1 activity in the livers of P30 Ahr b mice (P < .001) with nearly undetectable activity in PCBtreated Ahr d Cyp1a2(À/À) knockout mice and the corn oil-treated controls ( Fig. 2A ). There was a trend for higher EROD activity in the cerebellum of Ahr b Cyp1a2(À/À) knockout mice (P = .08) compared with all other groups (Fig. 2B ). Similar trends (P = .06) were seen in cortex (data not shown).
Assessment of oxidative stress
Glutathione levels were significantly higher (F 2,11 = 8.48; P < .05) in the liver of PCB-treated Ahr b Cyp1a2(À/À) knockout mice as well as levels of oxidized glutathione (GSSG) (F 2,11 = 16.75; P < .01), indicating that oxidative stress response had been induced in these animals. There were no differences by treatment or genotype for GSH levels in the cortex or cerebellum; however PCBtreated Ahr b Cyp1a2(À/À) knockout mice had significantly higher levels of GSSG in the cortex (F 2,11 = 9.97; P < .05) (Table 3) 
Motor function test results
Data from behavior experiments are presented in the order in which they were performed.
Rotarod results
There was a significant main effect of genotype with both groups of Cyp1a2(À/À) mice having shorter latencies to fall compared with wild type mice (F 2,205 = 14.74; P < .0001) and a significant main effect of treatment with PCB-treated mice having shorter latencies to fall (F 2,205 = 16.81; P < .0001). All groups of mice did show motor learning over the 5 days of testing with a significant main effect of day (F 4,587 = 75.83; P < .0001); however, there was a significant gene Â day interaction with Ahr b Cyp1a2
(+/ + ) wild type mice showing significantly greater improvements over the 5 days of testing (F 8,656 = 4.26; P < .0001. Female knockouts also showed the greatest impairments compared with controls ( Fig. 3A-D) .
Gait analysis
We found a significant main effect of genotype with both groups of Cyp1a2(À/À) mice having longer strides compared with wild type mice (F 2,248 = 16.95; P < .0001) and a significant gene Â treatment interaction (F 2,248 = 5.67; P < .01). Both lines of Cyp1a2(À/À) knockout mice had longer strides than wild type mice, and PCBtreated AhrbCyp1a2(+/+) wild type mice had shorter stride lengths than all other groups (Fig. 4A-B) . There was also a significant main effect of genotype for stride width (Fig. 4C) with Ahr b Cyp1a2(À/À) knockout mice having significantly narrower strides (F 2,248 = 10.48; P < .001). There were no significant differences by genotype or treatment for stride differential (P > .05).
Sticker removal
PCB-treated Ahr b Cyp1a2(À/À) knockout mice had the longest latencies to remove the adhesive sticker; however, the differences were not statistically significant (F 2,281 = 1.37; P = .26). There was a trend for a genotype effect (F 2,281 = 2.80; P = .062) with Ahr b Cyp1a2
(À/À) knockout mice having the longest latencies compared with wild type mice and Ahr d Cyp1a2(À/À) knockout mice (Fig. 5 ).
Pole test
There were no differences in the time to turn or the time to descend the pole based on treatment; however, females had significantly shorter turn (F 1,295 = 5.56; P < .05) and descent times Fig. 6A and B) .
Challenging balance beam
There was a significant main effect of genotype for latency to cross the balance beam with Ahr d Cyp1a2(À/À) knockout mice having significantly shorter latencies (F 2,121 = 3.36; P < .05) compared with Ahr b knockout and wild type mice (Fig. 7A ). There was a significant gene x treatment interaction (F 2,117 = 6.54; P < .01) for the number of slips with PCB-treated Ahr b mice having more slips while PCB-treated Ahr d Cyp1a2(À/À) knockout mice had significantly fewer slips (Fig. 7B) . There was also a significant gene x treatment interaction (F 2,117 = 6.07; P < .01) for the ratio of slips/ steps with PCB-treated Ahr b mice having more slips per step while PCB-treated Ahr d Cyp1a2(À/À) knockout mice had significantly fewer slips per step (Fig. 7C ).
Discussion and conclusions
Our data confirm that an environmentally relevant PCB mixture only activates the AHR in high-affinity Ahr b mice and that Cyp1a2 (+/+) wild type mice show fewer motor impairments following developmental PCB exposure. This supports our previous findings (Curran et al., 2011b (Curran et al., , 2012 and extends them to motor deficits. We did not find evidence of significant oxidative stress following PCB exposure, although it appears that the antioxidant response system had been activated, since both oxidized and reduced glutathione levels were significantly increased in the most susceptible Ahr b Cyp1a2(À/À) mice (Table 3) .
Our motor battery was designed to assess both nigrostriatal pathways and cerebellar function, and the data are consistent with impairments in those brain regions. PCB-treated mice from all three genotypes showed impaired performance on the rotarod compared to corn oil-treated controls,suggesting a cerebellar deficit. Motor learning was reduced in the two knockout lines Fig. 3 . A. Rotarod performance by genotype. There was a main effect of genotype with Cyp1a2(À/À) having significantly shorter latencies to fall off the rotarod. *** P < 0.001. B. Rotarod performance by treatment. There was a main effect of treatment on rotarod performance with PCB-treated mice having significantly shorter latencies to fall off the rotarod. *** P < .001. C. Rotarod performance over time (motor learning). All groups of mice showed improvement over 5 days of testing, but high-affinity Ahr b Cyp1a2(+/ + ) showed greater motor learning compared with Cyp1a2(À/À) knockout mice with a significant gene x day interaction. P < .001. D. Sex differences in rotarod performance. Female mice with the Cyp1a2(À/À) genotype showed the greatest impairments on the rotarod test compared with Cyp1a2(+/ + ) wild type mice. *P < .05, ** P < .01, *** P < .001.
compared with wild type mice. Interestingly, there was also a motor deficit in both corn oil-treated lines of Cyp1a2(À/À) mice. There is evidence to suggest CYP1A2 has a normal function in the brain. CYP1A2 is differentially regulated in the cortex and cerebellum (Iba et al., 2003) . The enzyme can also be induced in the brain in a region-specific manner with highest levels seen in the pons, medulla, cerebellum, frontal cortex (Yadav et al., 2006) and hypothalamus (Korkalainen et al., 2005) . CYP1A2 is normally down-regulated during cerebellar granule cell migration (MuleroNavarro et al., 2003) . Together with our findings, these data warrant further study of CYP1A2 0 s role in cerebellar development and function.
Results from the gait analysis did not support our hypothesis of genetic susceptibility in Cyp1a2(À/À) mice. In contrast, PCBtreated Ahr b Cyp1a2(+/+) mice had shorter strides than corn oiltreated control mice and both groups of PCB-treated knockout mice. Nigrostriatal lesions result in shorter strides (Fleming et al., 2004) , so this suggests some impairment in the PCB-treated wild type mice. We previously reported striatal dopamine levels were significantly lower in PCB-treated Ahr b Cyp1a2(À/À) mice compared with PCB-treated Ahr b Cyp1a2(+/+) mice (p < .01) (Curran et al., 2011a) , so it's unlikely this impairment was caused by an absolute loss of dopamine.
Our findings are consistent with Caudle et al. (2006) who reported a significant decrease in expression of the dopamine transporter (DAT) in PCB-treated C57BL/6J mice, but no difference in striatal dopamine levels. Bemis and Seegal (2004) reported that PCB mixtures inhibit the vesicular monoamine transporter (VMAT) in synaptosomes from adult Long-Evans rats. Interestingly, Akahoshi et al. (2009 Akahoshi et al. ( , 2012 demonstrated that the liganded AHR upregulates tyrosine hydroxylase, the rate-limiting enzyme in dopamine production. Together, this suggests future work is needed to examine the inter-related effects of PCB mixtures on dopamine production, metabolism and transport.
The major finding in the pole test was a shorter latency to turn and descend the pole by Ahr d Cyp1a2(À/À) knockout mice. This difference could result from increased anxiety and greater motivation to return to the home cage or hyperactivity which has also been reported in PCB neurotoxicity studies. Our prior studies with poor affinity Ahr d Cyp1a2(+/+) and Ahr d Cyp1a2(À/À) mice found no evidence of hyperactivity in open field locomotor testing, fewer zone crossings in the elevated zero maze (Curran et al., 2011b ) and a heightened startle response in Ahr d Cyp1a2(À/À) mice (Curran et al., 2012 showed a trend toward more slips, which can be an indication of an impairment in nigrostriatal function. Efforts to identify a mode of action responsible for the distinct patterns of PCB-induced motor impairments observed in these experiments will need to consider both the genetic differences and the well-established model of noncoplanar PCB neurotoxicity mediated by the ryanodine receptor (RyR) and calcium dysregulation (Dingemans et al., 2016; Pessah et al., 2010; Roegge and Schantz, 2006; Gafni et al., 2004) . We note that our PCB mixture does contain noncoplanar PCBs, but the congeners included do not have the same high potency at the ryanodine receptor as its prototypical agonist PCB 95. Therefore, it is likely that an alternate mechanism or mechanisms are needed to explain all of the observed effects. In support of that concept, Roegge and Schantz (2006) found increased levels of RyR1 in PCB-treated Long-Evans rats, but no evidence of increased receptor binding when looking at changes in the cerebellum. Meanwhile, Nguon et al. (2005) reported increased GFAP expression and reduced cerebellar mass in Sprague-Dawley rats exposed to Aroclor during development. Males had more severe motor impairments on rotarod and greater increases in GFAP compared with females. In contrast, we found Cyp1a2(+/ + ) wild type mice had significantly shorter strides than all other groups. ** P < .01.C. Gait stride width. Ahr b Cyp1a2(À/À) mice had significantly narrower strides compared with the other two genotypes, but there was no effect of PCB treatment. *** P < .001.
greater impairments in female mice. Llansola et al. (2009) identified the glutamate-NO-cGMP pathway as a cerebellar target of both coplanar PCB 126 and noncoplanar PCB 153 in Wistar rats. A follow-up study confirmed motor deficits for both PCB126 and PCB 153 with younger males at higher risk (Cauli et al., 2013) . A limitation of our studies was the use of gavage dosing. Although this allows precise dosing, it would be important to repeat these experiments using a chronic, low-level exposure in food. This is commonly done in rat studies (Miller et al., 2017; Roegge and Schantz, 2006; Widholm et al., 2003) , but can be a challenge when using mice which consume much smaller quantities of food each day. In addition, longer-term studies would allow an assessment of motor function in aged mice, which would better match the typical course of human Parkinson's disease patients. Since behavioral testing began at P60, it is possible that only minor impairments would be seen in nigrostriatal pathways at that age with more pronounced effects in animals over 1 yr of age.
Further work is needed to assess gene expression in the substantia nigra, striatum and cerebellum at multiple time points to verify that there were no adverse effects on dopaminergic Cyp1a2(À/À) mice having the longest latencies of all groups. P = .06. Fig. 6 . A. Pole turn time. There was a main effect of genotype, but no effect of PCB treatment with poor-affinity Ahr d Cyp1a2(À/À) mice having the shortest latencies to turn downward on the pole. * P < .05. B. Pole descent time. There was a main effect of genotype, but no effect of PCB treatment with poor-affinity Ahr d
Cyp1a2(À/À) having the shortest latencies to descend the pole back to the home cage. ** P < .01. mice having significantly fewer slips per step than their corn oil-treated controls. ** P < .01.
neurons involved in motor function and to identify potential modes of action for the observed motor deficits. A histological examination of those tissues could also reveal morphological changes related to abnormal development. It would also be important to look at changes related to thyroid hormone depletion, because we previously found that circulating thyroxine (T4) levels were reduced 80% in Ahr b Cyp1a2(À/À) knockout mice compared with control levels at P6 (Curran et al., 2011a) . Hydroxylated PCBs can cross the placenta (Meerts et al., 2002) and mimic the action of thyroid hormone (Giera et al., 2011; Darras, 2008) . Recent work has implicated CYP1A1 in metabolism of non-coplanar PCB congeners (Wadzinski et al., 2014; Gauger et al., 2007) to thyromimetic forms. Both 4-OH-PCB 107 (Berghuis et al., 2013) and OH-PCB 106 (Haijima et al., 2017) cause motor deficits, so it will be important to look into differential metabolism of parent congeners in the susceptible and resistant lines of mice.
Conclusions
Our data provides evidence that developmental exposure to PCBs lead to motor deficits consistent with adverse effects on cerebellar development and function as well as disruption of nigrostriatal pathways. The data presented here and our previous studies (Curran et al., 2011a (Curran et al., , 2011b provide strong evidence that allelic differences at the Ahr and Cyp1a2 loci affect developmental neurotoxicity to polychlorinated biphenyls. We have extended our previous studies on learning and memory deficits to demonstrate that high-affinity Ahr b Cyp1a2(À/À) knockout mice are uniquely susceptible to motor dysfunction following PCB exposure during gestation and lactation. By including corn oil-treated control mice of three genotypes in our studies, we also uncovered a previously unreported motor deficit in Cyp1a2(À/À) mice, regardless of Ahr genotype. Given known human variation in the aryl hydrocarbon receptor and CYP1A2, these studies support the use of our mouse model to explore developmental neurotoxicity of similar persistent organic pollutants and the role of CYP1A2 in normal brain development and function.
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